CareFusion Provides Update On Form 10-K Filing

CareFusion

today announced it has delayed filing its Annual Report on Form 10-K for the fiscal year ended June 30 beyond the Sept. 13 extended filing due date. As CareFusion indicated on Aug. 29, the company is consulting with the Securities and Exchange Commission (SEC) about its accounting policy for sales-type leases in its Pyxis® medication and supply dispensing product lines. As a result of the filing delay, the company received a notice from the New York Stock Exchange (NYSE) indicating CareFusion is not currently in compliance with continued listing requirements under the timely filing criteria outlined in Section 802.01E of the NYSE-Listed Company Manual. The issuing of such notices is considered routine practice in situations when there are late filings with the SEC. Under NYSE rules, CareFusion has six months from Sept. 13 to file its Form 10-K. Until CareFusion files its Form 10-K, CareFusion's common stock will remain listed on the NYSE under the symbol "CFN," but will be assigned a "LF" indicator to signify late filing status. The company can regain compliance with the NYSE listing standards at any time during this six-month period once it files its Form 10-K with the SEC.